Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma. (2021)

First Author: Hussein Z
Attributed to:  The effect of AIP mutations on the apoptotic RET pathway in pituitary adenomas funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/edm-21-0003

PubMed Identifier: 34110302

Publication URI: http://europepmc.org/abstract/MED/34110302

Type: Journal Article/Review

Volume: 2021

Parent Publication: Endocrinology, diabetes & metabolism case reports

ISSN: 2052-0573